Innovator IBD 50 ETF (NYSEARCA:FFTY) Shares Up 3.9% – Here’s What Happened

Innovator IBD 50 ETF (NYSEARCA:FFTYGet Free Report) rose 3.9% during trading on Monday . The company traded as high as $34.38 and last traded at $34.38. Approximately 204,959 shares traded hands during mid-day trading, an increase of 78% from the average daily volume of 115,135 shares. The stock had previously closed at $33.09.

Innovator IBD 50 ETF Price Performance

The stock’s fifty day moving average price is $31.89 and its 200 day moving average price is $29.58. The stock has a market capitalization of $85.95 million, a P/E ratio of 30.34 and a beta of 1.14.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Brookwood Investment Group LLC bought a new position in shares of Innovator IBD 50 ETF in the second quarter worth about $300,000. Atria Wealth Solutions Inc. bought a new position in Innovator IBD 50 ETF during the 2nd quarter worth about $976,000. Synergy Asset Management LLC bought a new position in Innovator IBD 50 ETF during the 2nd quarter worth about $1,956,000. Farther Finance Advisors LLC bought a new position in Innovator IBD 50 ETF during the 2nd quarter worth about $57,000. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Innovator IBD 50 ETF by 4.6% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 28,399 shares of the company’s stock worth $927,000 after acquiring an additional 1,238 shares in the last quarter.

About Innovator IBD 50 ETF

(Get Free Report)

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.

Further Reading

Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.